Update on the epidemiology of the rheumatic diseases

Current Opinion in Rheumatology

Volumn 9, Issue 2, 1997, Pages 90-94

  Hawker, Gillian ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

NONSTEROID ANTIINFLAMMATORY AGENT; STEROID;

BACKACHE; DISEASE COURSE; DISEASE PREDISPOSITION; DISEASE SEVERITY; DRUG USE; ENVIRONMENTAL FACTOR; HEREDITY; HIP FRACTURE; HUMAN; INTERVERTEBRAL DISK DEGENERATION; LIFESTYLE; LOW BACK PAIN; LUMBAR SPINE; MANIPULATIVE MEDICINE; MORTALITY; OSTEOARTHRITIS; OSTEOPOROSIS; PHYSICIAN; PREDICTION; PRIORITY JOURNAL; RHEUMATIC DISEASE; RHEUMATOID ARTHRITIS; RISK FACTOR; SHORT SURVEY; SIDE EFFECT; SPINE FUSION; WORK DISABILITY;

ARTHRITIS, RHEUMATOID; GREAT BRITAIN; HUMANS; INCIDENCE; LOW BACK PAIN; NETHERLANDS; OSTEOARTHRITIS; OSTEOPOROSIS; PREVALENCE; RHEUMATIC DISEASES; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; UNITED STATES;

EID: 0031006186     PISSN: 10408711     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002281-199703000-00002     Document Type: Short Survey

References (42)

1. Narayan P, Morris IM: A preliminary audit of the management of acute low back pain in the Kettering District [letter]. Br J Rheumatol 1995, 34:693-694.
2. Frymoyer JW: Back pain and sciatica. W Engl J Med 1988, 318:291-300.
3. Papageorgiou AC, Croft PR, Ferry S, Jayson MIV, Silman AJ: Estimating the prevalence of low back pain in the general population. Spine 1995, 20:1889-1894.
4. Carey TS, Evans AT, Hadler NM, Lieberman G, Kalsbeek WD, Jackman AM, Fryer JG, McNutt RA: Acute severe low back pain: a population-based study of prevalence and care-seeking. Spine 1996, 21:339-344. This prospective study examined the 1-year period prevalence of acute severe back pain, defined as pain associated with restricted activity, and examined the care-seeking behaviors of individuals with this syndrome. Characteristics and outcomes (satisfaction with care) for individuals seeking care for back pain from chiropractors versus physicians are compared.
5. Shekelle PG, Markovich M, Louie R: An epidemiologic study of episodes of back pain care. Spine 1995, 20:1668-1673.
6. Barrett S: Outcomes and costs of care for acute low back pain [letter]. N Engl J Med 1996, 334:329.
7. Goldstone RA: Outcomes and costs of care for acute low back pain [letter]. N Engl J Med 1996, 334:330.
8. Hampton JE: Outcomes and costs of care for acute low back pain [letter]. N Engl J Med 1996, 334:330.
9. Carey T: Outcomes and costs of care for acute low back pain [reply]. N Engl J Med 1996, 334:330.
10. Carey TS, Garrett J, Jackman A, McLaughlin C, Fryer J, Smucker DR, and the North Carolina Back Pain Project: The outcomes and costs of care for acute low back pain among patients seen by primary care practitioners, chiropractors, and orthopaedic surgeons. N Engl J Med 1995, 333:913-917.
11. Patrick DL, Deyo RA, Atlas SJ, Singer DE, Chapin A, Keller RB: Assessing health-related quality of life in patients with sciatica. Spine 1995, 22:1899-1909.
12. Katz JN: Lumbar spinal fusion. Spine 1995, 20:785-835. This is an excellent and thorough review of the literature covering the trends in rates of, and associated costs and complications from, lumbar spinal fusion surgery.
13. Battie MC, Videman T, Gibbons LE, Fisher LD, Manninen H, Gill K: 1995 Volvo Award in Clinical Sciences: determinants of lumbar disc degeneration. Spine 1995, 20:2601-2612. This methodologically rigorous study examines the independent effect of heredity versus environmental risk factors for lumbar disk degeneration in identical male twin pairs. The influence of heredity was stronger than measured environmental risk factors in determining disease.
14. Kelsey JL, Hochberg MC: Epidemiology of chronic musculoskeletal disorders. Am Rev Public Health 1980, 91:379-401.
15. Tepper S, Hochberg MC: Factors associated with hip osteoarthritis: data from the first National Health and Nutrition Examination Survey (NHANES 1). Am J Epidemiol 1993, 137:1081-1088.
16. La Plante MP: Data on Disability from the National Health Interview Survey 1983-1985: An InfoUse report. Washington DC: US National Institute on Disability and Rehabilitation Research; 1988.
17. Spector TD, Hart DJ, Leedham-Green M: The prevalence of knee and hand osteoarthritis (OA) in the general population using different clinical criteria: the Chingford study. Arthritis Rheum 1991, 34:S171.
18. Spector TD, Hochberg MC: Methodological problems in the epidemiological study of osteoarthritis. Ann Rheum Dis 1994, 53:143-146.
19. Aspelund G, Gunnarsdóttir S, Jónsson P, Jónsson H: Hand osteoarthritis in the elderly. Scand J Rheumatol 1996, 35:34-36.
20. Oliveria SA, Felson DT, Reed JI, Cirillo PA, Walker AM: Incidence of symptomatic hand, hip, and knee osteoarthritis among patients in a health maintenance organization. Arthritis Rheum 1995, 38:1134-1141.
21. Felson DT, Zhang Y, Hannan MT, Naimark A, Weissman BN, Alibadi P, Levy D: The incidence and natural history of knee osteoarthritis in the elderly. Arthritis Rheum 1995, 38:1500-1505.
22. McAlindon T, Zhang Y, Hannan M, Naimark A, Weissman B, Castelli W, Felson D: Are risk factors for patellofemoral and tibiofemoral knee osteoarthritis different? J Rheumatol 1996, 23:332-337.
23. Cooper C, McAlindon TE, Snow S, Vines K, Young P, Kirwan J, Dieppe P: Mechanical and constitutional risk factors for symptomatic knee osteoarthritis: differences between medial tibiofemoral and patellofemoral disease. J Rheumatol 1994, 21:307-313.
24. Odding E, Valkenburg HA, Algra D, Vandenouweland FA, Grobbee DE, Hofman A: Association of locomotor complaints and disability in the Rotterdam study. Ann Rheum Dis 1995, 54:721-725.
25. Johnell O, Gullberg B, Kanis JA, Allander E, Elffors L, Dequeker J, Dilsen G, Gennari C, Vaz AL, Lyritis G, Mazzuoli G, Miravet L, Passeri M, Cano RP, Rapado A, Ribot C: Risk factors for hip fracture in European women: the MEDOS study. J Bone Miner Res 1995, 10:1802-1815. This methodologically rigorous case-control study examines risk factors for hip fracture. The authors estimated that the hip fracture risk attributable to potentially modifiable risk factors was more than 50%. The most important lifestyle risk factors were milk intake and BMI.
26. Zukerman JD, Skovron ML, Koval KJ, Aharonoff G, Frankel VH: Postoperative complications and mortality associated with operative delay in older patients who have a fracture of the hip. J Bone Joint Surg Am 1995, 77:1551-1556.
27. Jones MA, Silman AJ, Whiting S, Barrett EM, Symmons DPM: Occurrence of rheumatoid arthritis is not increased in the first degree relatives of a population based inception cohort of inflammatory polyarthritis. Ann Rheum Dis 1996, 55:89-93.
28. del Junco DJ, Luthra HS, Annegers JF, Worthington JW, Kurland LT: The familial aggregation of rheumatoid arthritis and its relationship to the HLA-DR4 association. Am J Epidemiol 1984, 119:813-829.
29. Lawrence JS: The epidemiology and genetics of rheumatoid arthritis. In Population Studies and Genetics: Rheumatology. Edited by Lawrence JS. Basel, New York: Karger; 1969:1-36.
30. Hellgren L: Inheritance of rheumatoid arthritis. Acta Rheum Scand 1970, 16:211-216.
31. Van Der Heide A, Remme CA, Hofman DM, Jacobs JWG, Bijlsma JWJ: Predication of progression of radiologic damage in newly diagnosed rheumatoid arthritis. Arthritis Rheum 1995, 38:1466-1474. This prospective study in patients with newly diagnosed rheumatoid arthritis showed radiographic damage at 1 year to be greatest in individuals who were seropositive, had radiologic damage at baseline, and who had greater joint inflammation over the year. Specifically, joints that were more often inflamed were more likely to be damaged at 1 year.
32. Myllykangas-Luosujärvi RA, Aho K, Isomäki HA: Mortality in rheumatoid arthritis. Semin Arthritis Rheum 1995, 25:193-202.
33. Symmons DPM: Mortality in rheumatoid arthritis. Br J Rheumatol 1988, 27(suppl 1):44-54.
34. Symmons D: Excess mortality in rheumatoid arthritis: is it the disease or the drugs? [editorial]. J Rheumatol 1995, 22:2200-2202.
35. Myllykangas-Luosujärvi R, Aho K, Isomäki H: Death attributed to antirheumatic medication in a nationwide series of 1666 patients with rheumatoid arthritis who have died. J Rheumatol 1995, 22:2214-2217. This study utilized the Finnish registries to estimate that approximately 10% of the excess mortality in rheumatoid arthritis is attributable to antirheumatic medication, most notably nonsteroidal anti-inflammatory drugs and corticosteroids.
36. Pincus T, Callahan LF: Taking mortality in rheumatoid arthritis seriously: predictive markers, socioeconomic status and comorbidity. J Rheumatol 1986, 14:841-845.
37. Radis CD, Kahl LE, Baker GL, Wasko MCM, Cash JM, Gallatin A, Stolzer BL, Agarwal AK, Medsger TA Jr, Kwoh CK: Effects of cyclophosphamide on the development of malignancy and on long-term survival of patients with rheumatoid arthritis. Arthritis Rheum 1995, 38:1120-1127.
38. Verbrugge LM, Gates DM, Ike RW: Risk factors for disability among US adults with arthritis. J Clin Epidemiol 1991, 44:167-182.
39. Pincus T, Callahan LF, Sale WG, Brooks AL, Payne LE, Vaughn WK: Severe functional declines, work disability, and increased mortality in seventy-five rheumatoid arthritis patients studied over nine years. Arthritis Rheum 1984, 27:864-872.
40. Callahan LF, Bloch DA, Pincus T: Identification of work disability in rheumatoid arthritis: physical, radiographic and laboratory variables do not add explanatory power to demographic and functional variables. J Clin Epidemiol 1992, 45:127-138.
41. Reisine ST, Grady KE, Goodenow C, Fifield J: Work disability among women with rheumatoid arthritis: the relative importance of disease, social, work, and family factors. Arthritis Rheum 1989, 32:538-543.
42. Reisine S, McQuillan J, Fifield J: Predictors of work disability In rheumatoid arthritis patients: a five-year followup. Arthritis Rheum 1995, 38:1630-1647. This is a 5-year prospective study of individuals with rheumatoid arthritis (71% women) showing that work characteristics were less important in determining work disability at 5 years than were disease severity at baseline and the desire to be at home. These results are in contrast with prior work disability studies in rheumatoid arthritis that have consistently suggested that work disability in this group is best predicted by work characteristics, specifically the control over pace and activity of work.